APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 55 filers reported holding APPLIED THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $341,800 | +325.7% | 137,269 | +118.8% | 0.00% | – |
Q2 2023 | $80,294 | +4.8% | 62,730 | -33.6% | 0.00% | – |
Q1 2023 | $76,580 | -46.6% | 94,415 | -50.0% | 0.00% | – |
Q4 2022 | $143,510 | +63.1% | 188,830 | +100.0% | 0.00% | – |
Q3 2022 | $88,000 | -2.2% | 94,415 | 0.0% | 0.00% | – |
Q2 2022 | $90,000 | -90.0% | 94,415 | -77.9% | 0.00% | – |
Q1 2022 | $900,000 | -70.6% | 426,404 | +24.8% | 0.00% | – |
Q4 2021 | $3,058,000 | -41.3% | 341,651 | +8.8% | 0.00% | – |
Q3 2021 | $5,212,000 | -11.9% | 313,951 | +10.3% | 0.00% | – |
Q2 2021 | $5,913,000 | +31.1% | 284,569 | +18.3% | 0.00% | – |
Q1 2021 | $4,511,000 | -12.4% | 240,515 | +2.9% | 0.00% | – |
Q4 2020 | $5,147,000 | +3.7% | 233,835 | -2.2% | 0.00% | – |
Q3 2020 | $4,963,000 | -43.4% | 239,045 | -1.4% | 0.00% | -100.0% |
Q2 2020 | $8,767,000 | +92.9% | 242,526 | +74.4% | 0.00% | – |
Q1 2020 | $4,545,000 | +98.7% | 139,044 | +65.9% | 0.00% | – |
Q4 2019 | $2,287,000 | +1821.8% | 83,832 | +676.0% | 0.00% | – |
Q3 2019 | $119,000 | – | 10,803 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,025,464 | $19,227,000 | 12.53% |
EMERALD MUTUAL FUND ADVISERS TRUST | 644,572 | $12,089,000 | 0.40% |
Orbimed Advisors | 2,257,387 | $42,337,000 | 0.40% |
EMERALD ADVISERS, LLC | 554,279 | $10,396,000 | 0.38% |
Rock Springs Capital Management LP | 701,680 | $13,160,000 | 0.29% |
DSAM Partners (London) Ltd | 67,125 | $1,259,000 | 0.23% |
AlphaCentric Advisors LLC | 33,000 | $619,000 | 0.21% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 639,458 | $11,993,000 | 0.18% |
Artal Group S.A. | 400,000 | $7,502,000 | 0.13% |
Virtus ETF Advisers LLC | 12,438 | $233,000 | 0.10% |